Plans for the section Johnson&Johnson can favorably be reflected in growth rates of revenue in the future

The pharmaceutical giant of Johnson & Johnson Inc. declared (JNJ) plans to allocate a segment of consumer goods for health care in the independent company, having left in the portfolio pharmaceutical business on production medicines and medical devices. Whether there is an allocated company public, remains a subject of discussion. Division is planned to carry out within 18-24 months from the moment of the announcement and on the conditions which are not assuming taxation by tax...